دورية أكاديمية
Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.
العنوان: | Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer. |
---|---|
المؤلفون: | Suto, Hironobu, Okano, Keiichi, Oshima, Minoru, Ando, Yasuhisa, Matsukawa, Hiroyuki, Takahashi, Shigeo, Shibata, Toru, Kamada, Hideki, Kobara, Hideki, Tsuji, Akihito, Masaki, Tsutomu, Suzuki, Yasuyuki |
المصدر: | Pancreas; Mar2022, Vol. 51 Issue 3, p269-277, 9p |
قاعدة البيانات: | Complementary Index |
تدمد: | 08853177 |
---|---|
DOI: | 10.1097/MPA.0000000000002011 |